IM
NASDAQ · IMRN
Immuron Limited
Healthcare · Biotechnology
$1.10
Down-$0.03 (-2.65%)
Updated Aug 15, 2026, 5:43 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.09M
- P/E ratio
- -1.74
- Dividend yield
- 0.00%
- 52-week range
- $0.70 – $1.60
- Volume
- 33.3K
- Avg. volume
- 545.45K
Price performance
IMRN price history
1M range · 21 trading sessions · Daily adjusted prices
IMRN closed at $1.10 after 21 trading sessions, down 9.09% for the selected period.
- Last close
- $1.10
- Period change
- -9.09%
- Period low
- $1.03
- Period high
- $1.22
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $1.13 | $1.14 | $1.0301 | $1.10 | 33.3K |
| Aug 13, 2026 | $1.10 | $1.16 | $1.09 | $1.13 | 11.12K |
| Aug 12, 2026 | $1.09 | $1.13 | $1.09 | $1.1005 | 7.01K |
| Aug 11, 2026 | $1.11 | $1.135 | $1.0924 | $1.10 | 14.7K |
| Aug 10, 2026 | $1.09 | $1.15 | $1.0401 | $1.10 | 23.33K |
| Aug 7, 2026 | $1.0651 | $1.0651 | $1.02 | $1.031 | 9.25K |
| Aug 6, 2026 | $1.09 | $1.10 | $1.0353 | $1.10 | 12.15K |
| Aug 5, 2026 | $1.08 | $1.1538 | $1.05 | $1.10 | 7.24K |
| Aug 4, 2026 | $1.03 | $1.09 | $1.03 | $1.08 | 11.16K |
| Aug 3, 2026 | $1.13 | $1.13 | $1.03 | $1.06 | 44.47K |
| Jul 31, 2026 | $1.135 | $1.14 | $1.08 | $1.09 | 11.26K |
| Jul 30, 2026 | $1.08 | $1.14 | $1.0301 | $1.11 | 21.51K |
| Jul 29, 2026 | $1.0701 | $1.1199 | $1.04 | $1.095 | 32.63K |
| Jul 28, 2026 | $1.09 | $1.11 | $1.0639 | $1.095 | 6.85K |
| Jul 27, 2026 | $1.12 | $1.1202 | $1.06 | $1.06 | 36.17K |
| Jul 24, 2026 | $1.17 | $1.17 | $1.08 | $1.11 | 19.2K |
| Jul 23, 2026 | $1.11 | $1.1847 | $1.09 | $1.17 | 34.78K |
| Jul 22, 2026 | $1.22 | $1.22 | $1.11 | $1.13 | 47.67K |
| Jul 21, 2026 | $1.15 | $1.2299 | $1.11 | $1.22 | 36.3K |
| Jul 20, 2026 | $1.21 | $1.21 | $1.11 | $1.13 | 54.83K |
| Jul 17, 2026 | $1.12 | $1.22 | $1.0812 | $1.21 | 24.68K |
Latest IMRN news
The latest Smart Investors Daily articles mentioning IMRN.
Stock researchResearch & News · SEC Filings
Loading stock research…
